Digestive System Diseases

646 trials 307 recruiting

Filter these 646 trials by phase, country and sponsor.

Open in Search →

Colonic Intramural Injections of Botulin toxin versus placebo to treat fragmented defecation and urgency after restorative total mesorectal … Pending

2025-524342-96-00 Rectal Cancer 4
Tacrolimus as prophylaxis of post-ERCP pancreatitis Pending

2025-522900-26-00 Post-ERCP Pancreatitis 6
Impact of Biweekly and Triweekly Dosing Regimens Pending

2025-522305-38-00 Metastatic colorectal cancer 4
NEurotrophins MImetic compound for modulation of ischemia/reperfusion damage in Liver transplantation with Extended criteria Donors, a phase… Pending

2023-508977-10-00 Liver Transplant 9
Acute appendicitis and microbiota – etiology and effects of the antimicrobial treatment - MAPPAC Pending

2024-519392-26-00 Uncomplicated acute appendicitis 6
OV-PRIME-R (Oncolytic Virotherapy to enhance PReoperative IMmunotherapy Efficacy in patients with proficient mismatch repair (pMMR) Rectal c… Pending

2025-524375-23-00 Rectal cancer with proficient mismatch repair (pMMR) 3
Efficacy of sufentanil in urgent laparoscopic cholecystectomy: An alternative to the usual opioids for postoperative pain? Pending

2026-525783-18-00 Laparoscopic cholecystectomy 5
Efficacy of non operative treatment with amoxicillin/clavulanic acid versus surgical treatment in acute uncomplicated appendicitis in childr… Pending

2024-519402-12-00 uncomplicated appendicitis 5
Efficacy, Safety and Patient Satisfaction of Patient-Controlled Remimazolam Sedation. Pending

2026-525809-13-00 The trial will study sedation related to colonoscopy, t 6
Randomized controlled study comparing conventional antibiotic regimens versus antimicrobial strategies guided by epidemiological surveillanc… Pending

2024-519974-38-00 Hospitalized patients with decompensated cirrhosis, dia 6
COPE-CP: The effect of Celecoxib on pain, quality of life, use of opioids, and inflammation in patients suffering from chronic pancreatitis Pending

2025-522956-25-00 Chronic pancreatitis 5
Efficacy and safety of intravenous lidocaine versus placebo associated with intrathecal morphine analgesia in major digestive or abdominal s… Pending

2025-521206-18-00 Major patients receiving morphine spinal anaesthesia fo 5
PREDICTION OF COMPLICATIONS IN PATIENTS UNDERGOING SURGICAL TREATMENT OF HEPATIC TUMORS Pending

2025-524477-17-00 Hepatic tumor 6
Efficacy and safety of pharmacological therapy of obesity in liver transplant candidates Pending

2026-526044-12-00 Obesity 6
Mesotherapy treatment of irritable bowel syndrome Pending

2023-506950-18-00 Irritable bowel syndrome 4
Optimizing Lymph Node Staging in Esophageal Cancer with USPIO-enhanced MRI Pending

2023-506952-26-01 Esophageal cancer 4
ALBUMINUS: Dose reduction of human albumin during large-volume paracentesis in patients with cirrhosis Pending

2026-526167-38-00 liver cirrhosis 11
Multi-center, single-arm, phase II clinical trial evaluating efficacy and in-vivo homing of adoptively transferred autologous ex-vivo expand… Pending

2025-520628-11-00 Ulcerative colitis 4
The efficacy of oral vancomycin therapy in managing different phenotypes of paediatric inflammatory bowel diseases by correlating treatment … Pending

2025-524543-12-00 Ulcerative colitis 4
Safety study for the use of Rapamycin in children with familial adenomatous polyposis - RAPA-4-FAP Pending

2024-512079-11-00 Familial adenomatous polyposis 4
Cell-based immunotherapy in solid organ transplantation to minimize systemic immunosuppression Pending

2024-514866-37-01 Patients with end-stage liver disease undergoing liver 8
Clinical trial on the assessment of mucosal visualization quality and diagnostic performance in small bowel capsule endoscopy using differen… Pending

2025-520671-38-00 Comparison of diagnostic tools 11
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combination for Inflammatory Bowel Disease Pending

2025-524640-35-00 Ulcerative colitis (Inflammatory Bowel Disease) 4
CHILURSO: Efficacy of Ursodeoxycholic Acid versus Corticosteroids for the Treatment of Cholestatic Hepatitis Secondary to Immunotherapy Pending

2025-521317-50-00 Cholestatic hepatitis induced by immune checkpoint inhi 5